The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
GCLLSG 2016 | Conversations doctors must have with CLL patients
Federico Caligaris-Cappio, MD of Università Vita-Salute San Raffaele, Milan, Italy, talks about how he thinks doctors should interact with their chronic lymphocytic leukemia (CLL) patients at the 2016 International Workshop of the German CLL Study Group (GCLLSG) in Cologne, Germany. Prof. Caligris-Cappio explains that he thinks it is essential for doctors to listen to the patients. It is important to talk to them and tell them about the problems and solutions but listening to them and trying to understand their fears and expectations is even more important. In that way, the strategy of treatment can be tailored for the particular patient based on the way they feel. Some fears can be lowered as doctors can explain solutions to these fears. Other fears may not be able to be lowered but have to be spoken frankly and honestly about while always giving hope. He believes that giving hope to patients is an extremely important role for doctors.
